Psychedelics in Palliative Care: Clinical and Ethical Considerations
Rohini Kanniganti, MD, MSPH, HMDC
Anthony P. Bossis, PhD
Sunil Aggarwal, MD, PhD, FAAPMR, FAAHPM
Monday 27 October, 2025 7PM CET (6PM GMT, 2PM ET, 11AM PT)
Online via Zoom
Add to Calendar
Death is the one threshold we all must cross. It is both inevitable and deeply human, a passage that raises profound psychological, existential, and spiritual questions. For those living with terminal illness, the approach of death can bring fear, anxiety, and despair, but also opportunities for reconciliation, meaning, and even transcendence.
Psychedelic-assisted therapy is increasingly being studied as a way to support people at the end of life. Research has shown psilocybin’s potential to ease depression and anxiety in patients facing life-threatening diagnoses, while clinical and legal work continues to explore how these therapies might be integrated into palliative care. Alongside the science, psychedelics invite us to engage with death in its sacred dimension, reminding us that this is not only a clinical concern but a universal human experience that asks for presence, humility, and care.
This 90-minute panel brings together leading voices at the intersection of psychedelics and end-of-life care. Rohini Kanniganti, M.D., Associate Medical Director at Mountain Valley Hospice and Palliative Care (North Carolina), will bring a frontline perspective on the clinical, relational, and spiritual realities of hospice work. Anthony P. Bossis, Ph.D. (NYU School of Medicine), co-investigator of the landmark 2016 psilocybin trial with cancer patients, will share insights from his research into how psilocybin can help cultivate peace, acceptance, and spiritual well-being at the end of life. Sunil Aggarwal, M.D., Ph.D. (AIMS Institute, Seattle), a palliative care physician and medical geographer, will discuss his pioneering work providing psychedelic care for terminally ill patients and his legal efforts to secure psilocybin access under “Right to Try” laws.
Your Key Insights and Takeaways
By attending, you will:
- Gain an overview of global research into psychedelics for end-of-life care
- Explore therapeutic mechanisms for addressing existential, psychological, and spiritual suffering
- Learn about ethical, legal, and policy challenges shaping access to psychedelic therapies
- Reflect on death as a universal threshold that calls for both scientific rigour and reverence for the sacred
Designed for Professionals Like You
This event is designed for mental health professionals, clinicians, and researchers who want to deepen their understanding of psychedelic-assisted approaches to palliative care while also engaging with the existential and spiritual dimensions of dying. It is the first in an ongoing series exploring the diverse clinical applications of psychedelic therapy across different diagnoses.